Research Study

Beta-Caryophyllene, a Cannabinoid Receptor Type 2 Selective Agonist, in Emotional and Cognitive Disorders.

📅 2024 🔗 DOI: 10.3390/ijms25063203
Citation
Ricardi C., Barachini S., Consoli G., Marazziti D., Polini B. et al. (2024). Beta-Caryophyllene, a Cannabinoid Receptor Type 2 Selective Agonist, in Emotional and Cognitive Disorders.. Int J Mol Sci. DOI: 10.3390/ijms25063203
View Full Study →

Abstract

Abstract not available. See citation for source.

Disclaimer: This research summary is for educational purposes only. Always consult with a healthcare professional before making decisions based on scientific research.